| Financial Year |
March 31 2023 |
| Monetary Funds |
891,253,462.85 |
| Held-for-trading Financial Assets |
10,000.00 |
| Notes Receivable |
18,247,883.57 |
| Accounts Receivable |
596,276,339.97 |
| Advances to Suppliers |
687,002,211.18 |
| Other Receivables |
69,075,989.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
814,489.24 |
| Inventories |
391,427,470.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
148,591,906.38 |
| Total Current Assets |
3,422,149,610.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
478,238,292.02 |
| Investment Properties |
11,031,502.60 |
| Fixed Assetes |
444,441,659.90 |
| Under-construction Projects |
78,900,481.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
230,289,549.83 |
| R&D expenses |
-- |
| Goodwill |
33,991,460.53 |
| Long-Term Deferred and Prepaid Expenses |
236,958.86 |
| Deferred Income Tax Assets |
112,312,015.19 |
| Other Non-Current Assets |
129,099,273.90 |
| Sub-Total of Non-Current Assets |
1,840,805,203.39 |
| Total Assets |
5,262,954,813.90 |
| Short-Term Loans |
546,226,089.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
781,872.38 |
| Accounts Payable |
521,694,087.67 |
| Accounts Received In Advance |
381,978.55 |
| Employee Compensation Payable |
29,824,217.53 |
| Taxes Payable |
25,414,484.27 |
| Interest Payable |
-- |
| Dividend Payable |
785,961.22 |
| Other payables |
38,362,608.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
282,484,555.52 |
| Other Current Liabilities |
2,440,678.09 |
| Sub-Total of Current Liabilities |
2,098,058,161.10 |
| Long-term Loans |
524,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
41,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,378,588.81 |
| Deferred Income Tax Liabilities |
2,606,184.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
598,801,912.55 |
| Total Liabilities |
2,696,860,073.65 |
| Paid-In Capital(Or Share Stock) |
1,346,857,772.00 |
| Capital Surplus |
814,867,318.87 |
| Surplus Reserve |
52,939,841.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
263,293,138.27 |
| Minority Stockholder's Interest |
65,727,125.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,500,367,614.74 |
| Owner's Equity（Stockholder's Equity） |
2,566,094,740.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,262,954,813.90 |
